PAMG
NVO

Patton Albertson Miller Group’s Novo Nordisk NVO Stock Holding History

Patton Albertson Miller Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,337
Closed -$221K – 216
2025
Q4 		$221K Sell
4,337
-563
-11% -$28.8K 0.03% 208
2025
Q3 		$272K Sell
4,900
-230
-4% -$13.5K 0.03% 187
2025
Q2 		$354K Hold
5,130
– – 0.05% 176
2025
Q1 		$356K Sell
5,130
-350
-6% -$28.9K 0.05% 167
2024
Q4 		$471K Sell
5,480
-240
-4% -$26K 0.06% 152
2024
Q3 		$681K Sell
5,720
-180
-3% -$24K 0.09% 133
2024
Q2 		$842K Sell
5,900
-80
-1% -$10.6K 0.12% 118
2024
Q1 		$768K Sell
5,980
-200
-3% -$23.8K 0.12% 120
2023
Q4 		$639K Sell
6,180
-200
-3% -$19.8K 0.11% 132
2023
Q3 		$580K Sell
6,380
-300
-4% -$26.4K 0.11% 141
2023
Q2 		$541K Sell
6,680
-952
-12% -$77.8K 0.1% 145
2023
Q1 		$607K Sell
7,632
-2,068
-21% -$147K 0.11% 148
2022
Q4 		$656K Sell
9,700
-550
-5% -$32.2K 0.12% 141
2022
Q3 		$511K Hold
10,250
– – 0.11% 151
2022
Q2 		$571K Sell
10,250
-1,000
-9% -$55.5K 0.12% 149
2022
Q1 		$625K Sell
11,250
-900
-7% -$46.2K 0.11% 161
2021
Q4 		$680K Sell
12,150
-320
-3% -$17.3K 0.11% 158
2021
Q3 		$599K Sell
12,470
-2,330
-16% -$113K 0.11% 158
2021
Q2 		$620K Sell
14,800
-750
-5% -$29.1K 0.14% 127
2021
Q1 		$524K Sell
15,550
-834
-5% -$29.7K 0.13% 138
2020
Q4 		$615K Sell
16,384
-166
-1% -$5.74K 0.15% 129
2020
Q3 		$575K Hold
16,550
– – 0.16% 126
2020
Q2 		$542K Hold
16,550
– – 0.16% 136
2020
Q1 		$498K Sell
16,550
-1,550
-9% -$46.2K 0.17% 135
2019
Q4 		$524K Hold
18,100
– – 0.14% 158
2019
Q3 		$468K Sell
18,100
-82
-0.5% -$2.07K 0.13% 165
2019
Q2 		$457K Buy
+18,182
New +$449K 0.13% 161

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Patton Albertson Miller Group's NVO Position: Q1 2026 in Review

Patton Albertson Miller Group sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 4,337 shares — an estimated $221K sold.

Patton Albertson Miller Group first reported a position in NVO in Q2 2019 and held it in 27 quarters. The position peaked at $842K in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Patton Albertson Miller Group reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Patton Albertson Miller Group sold 4,337 Novo Nordisk shares in Q1 2026, an estimated $221K.
  • Patton Albertson Miller Group first reported a position in Novo Nordisk in Q2 2019 and held it in 27 quarters.
  • Patton Albertson Miller Group's Novo Nordisk position peaked at $842K in Q2 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Patton Albertson Miller Group's 13F filing for Q1 2026, filed 21 Apr 2026.